Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CABLES1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LEPROT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NDUFAF7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AMOTL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAREM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AGMAT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD59 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGFR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
KMT5A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PNMA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF4ENIF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SFTPD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELOVL6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
JAG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NSMCE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DIS3L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCCB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF3K - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on